Drugs Made In America Acquisition Corp. (DMAAR)
Market Open
10 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 13
0
0%
$
286.63M Market Cap
- P/E Ratio
- Div Yield
801 Volume
- Eps
$ 0.13
Previous Close Want to track DMAAR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| SK Steven Katznelson Radcliffe Capital Management LP | 143,911 | $31,286.25 | $22,781.11 | -$8,505.14 | -27.18% |
| VL Vincent Leva Linden Advisors LP | 850,000 | $184,790 | $134,555 | -$50,235 | -27.18% |
| BO Brian Oliveira Clear Street Group Inc. | 711,088 | $141,013.07 | $90,592.61 | -$50,420.46 | -35.76% |
